We are monitoring the impact of COVID-19 on Asia Pacific Haemostatic Agents Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 4374
Share on
Share on

Asia Pacific Haemostatic Agents Market Research Report – Segmented By Type, Treatment, End User and Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC) – Industry Size, Share, Trends and Growth Forecast (2021 to 2026)

Pulished: April, 2021
ID: 4374
Pages: 185

The size of the Haemostatic Agents Market in the Asia Pacific is forecasted to increase at a promising CAGR from 2021 to 2026.

Y-O-Y growth in the number of trauma and surgical cases in the APAC region and technology advances are some of the factors propelling the market forward. An increase in the number of surgical procedures is one of the key drivers of APAC's Haemostatic agents market growth. Surgical care is required to address a variety of health disorders, including cardiovascular illnesses, traumas, cancer, obstructed labor, birth abnormalities, and other conditions, as recognized by WHO and several other international organizations. In addition, Y-O-Y rise in the incidence of hemorrhage post-surgery and the growing emphasis on blood control are further estimated to accelerate the APAC region's market growth. Furthermore, technological advancements in surgical procedures, such as robot-assisted surgery and an aging population, are expected to drive the APAC hemostatic agents market.

The demand for hemostats has risen in tandem with the prevalence of chronic diseases, cesarean deliveries, fatal traumas, and significant organ procedures. These medications enable patients with hemostatic illnesses and nonanatomic and sensitive structures to avoid blood loss during surgical procedures. Its widespread use among healthcare professionals has contributed to its widespread adoption and helped to reduce treatment costs. Furthermore, due to technological advancements, notable manufacturers have produced absorbable adjunctive hemostats that assist experts in managing disruptive bleeding more effectively than in prior ways.

However, the APAC market for hemostatic agents is expected to be hampered by the high frequency of blood clotting disorders in countries such as China and India and a lack of information about hemostatic diagnostics in the Asia Pacific. Rural areas with high per capita income have increased their use of diagnostic and therapeutic agents, putting a strain on patient care. Certain government criteria and stringent norms have been implemented to strengthen the healthcare infrastructure.

This research report on the Asia Pacific haemostatic agents market has been segmented and sub-segmented into the following categories:

  • By Type: Thrombin Based Haemostats, Gelatin Based Haemostats, Collagen Based Haemostats, Oxidized Regenerated Cellulose Based Haemostats, Combination Haemostats, Fibrin Sealants, and Others
  • By Treatment: Cardiovascular, General Surgery, Digestive Surgery, Neurosurgery, and Others      
  • By End User: Hospitals, Surgery Centres, Nursing Homes, and Others      
  • By Country: India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore, and the Rest of APAC

Regionally, Asia-Pacific is expected to grow rapidly in the coming years, as is evident from the high CAGR value for the region. In addition to having the highest growth rate, the region also has the third-highest market share. The region's rapid growth can be attributed to the developing stature of countries such as India and China.

The increased knowledge of the advantages of biosurgery over traditional surgical approaches is one of the primary reasons driving regional market expansion. In addition, a growing focus on healthcare technical developments for creating new and innovative goods and an increasing need for minimally invasive surgery are expected to boost the APAC market.

According to the Centers for Disease Control and Prevention, the prevalence rate of hemophilia, a bleeding disorder, is 1 in every 5000 male births. Due to the fact that this illness can only be treated by surgery, proper bleeding control equipment is essential.

KEY MARKET PLAYERS:

Companies dominating the Asia Pacific Haemostatic Agents Market profiled in this report are Ethicon, Pfizer, Baxter International, R. Bard, The Medicines Company, Anika Therapeutics, Advanced Medical Solutions, Integra LifeSciences, B Braun Melsungen, Gelita Medical, Equimedical, Vascular Solutions, Marine Polymer Technologies, and Z-Medica.

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Type                              

                                5.1.1 Introduction           

                                5.1.2 Thrombin Based Haemostats          

                                5.1.3 Gelatin Based Haemostats               

                                5.1.4 Collagen Based Haemostats            

                                5.1.5 Oxidized Regenerated Cellulose Based Haemostats             

                                5.1.6 Combination Haemostats 

                                5.1.7 Fibrin Sealants       

                                5.1.8 Others      

                                5.1.9  Y-o-Y Growth Analysis, By Type    

                                5.1.10  Market Attractiveness Analysis, By Type                

                                5.1.11  Market Share Analysis, By Type  

                5.2 Treatment                  

                                5.2.1 Introduction           

                                5.2.2 Cardiovascular       

                                5.2.3 General Surgery   

                                5.2.4 Digestive Surgery 

                                5.2.5 Neurosurgery        

                                5.2.6 Others      

                                5.2.7 Y-o-Y Growth Analysis, By Treatment          

                                5.2.8 Market Attractiveness Analysis, By Treatment        

                                5.2.9 Market Share Analysis, By Treatment         

                5.3 End User                      

                                5.3.1 Introduction           

                                5.3.2 Hospitals  

                                5.3.3 Surgery Centres    

                                5.3.4 Nursing Homes     

                                5.3.5 Others      

                                5.3.6 Y-o-Y Growth Analysis, By End User             

                                5.3.7  Market Attractiveness Analysis, By End User          

                                5.3.8  Market Share Analysis, By End User            

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Type

                                                6.1.3.3 By Treatment

                                                6.1.3.4 By End User

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Type

                                                6.1.4.3 By Treatment

                                                6.1.4.4 By End User

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Type

                                                6.1.5.3 By Treatment

                                                6.1.5.4 By End User

                6.2 China                             

                6.3 India                              

                6.4 Japan                            

                6.5 South Korea                               

                6.6 Australia                      

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 Ethicon                         

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Pfizer                            

                8.3 Baxter International                               

                8.4 R. Bard                          

                8.5 The Medicines Company                      

                8.6 Anika Therapeutics                 

                8.7 Advanced Medical Solutions                               

                8.8 Integra Life Sciences                               

                8.9 Gelita Medical                           

                8.10 Z-Medica                   

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Market Outlook and Investment Opportunities                                         

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms by type, packaging and meat type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the North america market; which includes broadly demographic, economic and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Asia Pacific Haemostatic Agents Market, By Type, From 2021 to 2026 (USD Million)
  2. Asia Pacific Thrombin Based Market, By Region, From 2021 to 2026 (USD Million)
  3. Asia Pacific Gelatin Based Market, By Region, From 2021 to 2026 (USD Million)
  4. Asia Pacific Collagen Based Market, By Region, From 2021 to 2026 (USD Million)
  5. Asia Pacific Oxidized Regenerated Cellulose Based Market, By Region, From 2021 to 2026 (USD Million)
  6. Asia Pacific Combination Haemostats Market, By Region, From 2021 to 2026 (USD Million)
  7. Asia Pacific Fibrin Sealants Market, By Region, From 2021 to 2026 (USD Million)
  8. Asia Pacific Others Market, By Region, From 2021 to 2026 (USD Million)
  9. Asia Pacific Haemostatic Agents Market, By Treatment, From 2021 to 2026 (USD Million)
  10. Asia Pacific Cardiovascular Market, By Region, From 2021 to 2026 (USD Million)
  11. Asia Pacific General Surgery Market, By Region, From 2021 to 2026 (USD Million)
  12. Asia Pacific Digestive Surgery Market, By Region, From 2021 to 2026 (USD Million)
  13. Asia Pacific Neurosurgery Market, By Region, From 2021 to 2026 (USD Million)
  14. Asia Pacific Others Market, By Region, From 2021 to 2026 (USD Million)
  15. Asia Pacific Haemostatic Agents Market, By End Users, From 2021 to 2026 (USD Million)
  16. Asia Pacific Hospitals Market, By Region, From 2021 to 2026 (USD Million)
  17. Asia Pacific Surgery Centres Market, By Region, From 2021 to 2026 (USD Million)
  18. Asia Pacific Nursing Homes Market, By Region, From 2021 to 2026 (USD Million)
  19. Asia Pacific Others Market, By Region, From 2021 to 2026 (USD Million)
  20. Japan Haemostatic Agents Market, By Type, From 2021 to 2026 (USD Million)
  21. Japan Haemostatic Agents Market, By Treatment, From 2021 to 2026 (USD Million)
  22. Japan Haemostatic Agents Market, By End Users, From 2021 to 2026 (USD Million)
  23. China Haemostatic Agents Market, By Type, From 2021 to 2026 (USD Million)
  24. China Haemostatic Agents Market, By Treatment, From 2021 to 2026 (USD Million)
  25. China Haemostatic Agents Market, By End Users, From 2021 to 2026 (USD Million)
  26. India Haemostatic Agents Market, By Type, From 2021 to 2026 (USD Million)
  27. India Haemostatic Agents Market, By Treatment, From 2021 to 2026 (USD Million)
  28. India Haemostatic Agents Market, By End Users, From 2021 to 2026 (USD Million)
  29. Australia Haemostatic Agents Market, By Type, From 2021 to 2026 (USD Million)
  30. Australia Haemostatic Agents Market, By Treatment, From 2021 to 2026 (USD Million)
  31. Australia Haemostatic Agents Market, By End Users, From 2021 to 2026 (USD Million)
  32. South Korea Haemostatic Agents Market, By Type, From 2021 to 2026 (USD Million)
  33. South Korea Haemostatic Agents Market, By Treatment, From 2021 to 2026 (USD Million)
  34. South Korea Haemostatic Agents Market, By End Users, From 2021 to 2026 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample